Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 13.
doi: 10.1007/s00330-025-11625-x. Online ahead of print.

European Society of Urogenital Radiology (ESUR) guidelines on MR imaging prior to fertility-sparing treatments in patients with cervical, endometrial, and ovarian cancers

Benedetta Gui  1 , Luca Russo  2   3 , Nishat Bharwani  4   5 , Teresa Margarida Cunha  6 , Carlos Nicolau  7 , Carlos Carnelli  8 , Francesco Fanfani  9   10 , Denis Querleu  9 , Pamela Causa Andrieu  11 , Yulia Lakhman  12 , Stefania Rizzo  13 , Evis Sala  1   14 , Stephanie Nougaret  15   16 , Lucia Manganaro  17
Affiliations

European Society of Urogenital Radiology (ESUR) guidelines on MR imaging prior to fertility-sparing treatments in patients with cervical, endometrial, and ovarian cancers

Benedetta Gui et al. Eur Radiol. .

Abstract

Objective: To establish standardised MRI protocols and structured reporting guidelines for optimal patient selection in fertility-sparing treatments for gynaecological cancers.

Methods: The European Society of Urogenital Radiology (ESUR) Female Pelvis Working Group utilised the RAND-UCLA Appropriateness Method to develop these guidelines. A multidisciplinary panel composed of ten radiologists and two gynaecological oncologists conducted a comprehensive review of clinical and imaging literature (until 28th February 2025) and evaluated MRI protocols through a structured survey consisting of 104 questions across five sections covering MR imaging preparation, equipment specifications, protocols, and reporting standards. Recommendations achieving ≥ 80% consensus were designated as "RECOMMENDED", with those below this threshold marked as "SUGGESTED" or "NOT RECOMMENDED".

Results: Consensus was reached on MRI technical requirements, including sequence selection, imaging planes, and contrast timing. Disease-specific structured reporting templates were developed with standardised criteria for cervical, endometrial and ovarian cancers.

Conclusions: These evidence-based guidelines provide a standardised framework for MRI acquisition and reporting to support optimal patient selection for fertility-sparing treatments. By harmonising imaging protocols and structured reporting, we aim to enhance diagnostic accuracy and clinical decision-making. These guidelines represent a key step toward developing comprehensive recommendations for fertility preservation, with future validation and adaptation ensuring their applicability across diverse clinical settings.

Key points: Question Fertility-sparing treatments in gynaecological cancers require adherence to strict selection criteria based on tumour stage, size, and histological subtype. Findings MRI is essential for accurately assessing eligibility criteria in cervical and endometrial cancers, and characterising adnexal masses using standardised reporting criteria. Clinical relevance MRI is valuable for the preoperative evaluation of patients considered for fertility-sparing treatments in gynaecologic cancers. Key parameters include precise tumour measurements, depth of invasion, and local tumour extent through optimised protocols combining anatomical and functional sequences.

Keywords: Endometrial neoplasms; Fertility preservation; Magnetic resonance imaging; Ovarian neoplasms; Uterine cervical neoplasms.

PubMed Disclaimer

Conflict of interest statement

Compliance with ethical standards. Guarantor: The scientific guarantor of this publication is Dr. Benedetta Gui. Conflict of interest: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article. Statistics and biometry: No complex statistical methods were necessary for this paper. Informed consent: Not applicable. Ethical approval: Institutional Review Board approval was not required for this special report. Study subjects or cohorts overlap: Not applicable. Methodology: Recommendations

Similar articles

See all similar articles

References

    1. Taylan E, Oktay K (2019) Fertility preservation in gynecologic cancers. Gynecol Oncol 155:522–529 - PubMed - DOI
    1. Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229–263 - PubMed - DOI
    1. Stewart K, Campbell S, Frumovitz M, Ramirez PT, McKenzie LJ (2021) Fertility considerations prior to conservative management of gynecologic cancers. Int J Gynecol Cancer 31:339–344 - PubMed - DOI
    1. La Rosa VL, Garzon S, Gullo G et al (2020) Fertility preservation in women affected by gynaecological cancer: the importance of an integrated gynaecological and psychological approach. Ecancermedicalscience 14:1035 - PubMed - PMC
    1. Morice P, Scambia G, Abu-Rustum NR et al (2024) Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: guidelines from ESGO, ESHRE, and ESGE. Lancet Oncol 25:e602–e610 - PubMed - DOI

LinkOut - more resources